US SB1820 | 2019-2020 | 116th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 24-2-1)
Status: Introduced on June 12 2019 - 25% progression, died in committee
Action: 2019-06-12 - Read twice and referred to the Committee on Commerce, Science, and Transportation.
Pending: Senate Commerce, Science, And Transportation Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 12 2019 - 25% progression, died in committee
Action: 2019-06-12 - Read twice and referred to the Committee on Commerce, Science, and Transportation.
Pending: Senate Commerce, Science, And Transportation Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Establishes the Horseracing Anti-Doping and Medication Control Authority as an independent, private non-profit corporation with responsibility for developing and administering an anti-doping and medication control program for (1) Thoroughbred, Quarter, and Standardbred horses that participate in horse races; and (2) the personnel engaged in the care, training, or racing of such horses. The Federal Trade Commission shall have oversight over the authority. An interstate compact may be established after five years to take over the authority's duties. The sale of a Thoroughbred, Quarter, or Standardbred horse shall be considered an unfair or deceptive act or practice if the seller (1) knows or has reason to know the horse has been administered a substance that the authority determines has a long-term degrading effect on the soundness of the horse, and (2) fails to disclose to the buyer the administration of such substance.
Title
Horseracing Integrity Act of 2019
Sponsors
Sen. Kirsten Gillibrand [D-NY] | Sen. Martha McSally [R-AZ] | Sen. Jeanne Shaheen [D-NH] | Sen. Susan Collins [R-ME] |
Sen. Cory Booker [D-NJ] | Sen. Gary Peters [D-MI] | Sen. Bernard Sanders [I-VT] | Sen. Chris Van Hollen [D-MD] |
Sen. Christopher Murphy [D-CT] | Sen. Richard Durbin [D-IL] | Sen. Tammy Duckworth [D-IL] | Sen. Dianne Feinstein [D-CA] |
Sen. Jack Reed [D-RI] | Sen. Richard Blumenthal [D-CT] | Sen. Margaret Hassan [D-NH] | Sen. Tammy Baldwin [D-WI] |
Sen. Kamala Harris [D-CA] | Sen. Charles Schumer [D-NY] | Sen. Patrick Leahy [D-VT] | Sen. Sheldon Whitehouse [D-RI] |
Sen. Elizabeth Warren [D-MA] | Sen. Amy Klobuchar [D-MN] | Sen. Jacky Rosen [D-NV] | Sen. Catherine Cortez Masto [D-NV] |
Sen. Brian Schatz [D-HI] | Sen. Tina Smith [D-MN] | Sen. Edward Markey [D-MA] |
History
Date | Chamber | Action |
---|---|---|
2019-06-12 | Senate | Read twice and referred to the Committee on Commerce, Science, and Transportation. |
Same As/Similar To
HB1754 (Related) 2020-09-30 - Received in the Senate.
Subjects
Administrative law and regulatory procedures
Animal protection and human-animal relationships
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug, alcohol, tobacco use
Gambling
Government studies and investigations
Intergovernmental relations
Mammals
Medical ethics
Professional sports
Sports and recreation
State and local government operations
Veterinary medicine and animal diseases
Animal protection and human-animal relationships
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug, alcohol, tobacco use
Gambling
Government studies and investigations
Intergovernmental relations
Mammals
Medical ethics
Professional sports
Sports and recreation
State and local government operations
Veterinary medicine and animal diseases
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/1820/all-info |
Text | https://www.congress.gov/116/bills/s1820/BILLS-116s1820is.pdf |